PE of 7.6 to 7.8 Based on Earnings Estimates??? | BMY Message Board Posts


Bristol-Myers Squibb Co.

  BMY website

BMY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  8224 of 8458  at  10/27/2021 12:06:37 PM  by

Biotech2050


 In response to msg 8223 by  Paul777333
view thread

Re: PE of 7.6 to 7.8 Based on Earnings Estimates???

Yes my ACAD friend you are missing something.
 
There is a huge difference between GAAP and Non GAAP EPS. You are looking at the latter which excludes the intangible amortization primarily relating to the Celgene acquisition. Let me try to explain this mathematically in layman’s terms (i try):
 
ACAD was making a profit of say $1B and had 100M shares outstanding. No amortization. So GAAP & NON GAAP EPS are both $10.
 
ACAD acquires TGTX for $30B and all patents expire in 5 years. TGTX generates $6B in profits. Annual amortization is also $6B.
 
ACAD would have a GAAP EPS of $1B + $6B less $6B amortization = $1B
 
ACAD would have a non GAAP EPS of $1B + $6B = $7B! 
The annual BMY amortization is TOO HUGE TO IGNORE and it primarily relates to Revlimid revenues. It is circa $10B annually for the next 3 years = ~$4.50 per share.
 
Now tell me which EPS should you be looking at!  
 
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 2  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
8226 Re: PE of 7.6 to 7.8 Based on Earnings Estimates??? tocentsworth 1 10/27/2021 2:21:15 PM
8236 Re: PE of 7.6 to 7.8 Based on Earnings Estimates??? Paul777333 4 10/27/2021 7:02:52 PM


Financial Market Data provided by
.
Loading...